Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 240

1.

Primary Penile Cancer: The Role of Adjuvant Radiation Therapy in the Management of Extranodal Extension in Lymph Nodes.

Johnstone PAS, Boulware D, Djajadiningrat R, Ottenhof S, Necchi A, Catanzaro M, Ye D, Zhu Y, Nicolai N, Horenblas S, Spiess PE.

Eur Urol Focus. 2018 Oct 13. pii: S2405-4569(18)30300-6. doi: 10.1016/j.euf.2018.10.007. [Epub ahead of print]

PMID:
30327282
2.

Impact of PI3K-AKT-mTOR Signaling Pathway Up-regulation on Prognosis of Penile Squamous-Cell Carcinoma: Results From a Tissue Microarray Study and Review of the Literature.

Azizi M, Tang DH, Verduzco D, Peyton CC, Chipollini J, Yuan Z, Schaible BJ, Zhou JM, Johnstone PA, Giuliano A, Dhillon J, Spiess PE.

Clin Genitourin Cancer. 2018 Sep 22. pii: S1558-7673(18)30153-8. doi: 10.1016/j.clgc.2018.09.012. [Epub ahead of print]

PMID:
30318447
3.

Current controversies and developments on the role of lymphadenectomy for penile cancer.

Azizi M, Chipollini J, Peyton CC, Cheriyan SK, Spiess PE.

Urol Oncol. 2018 Oct 6. pii: S1078-1439(18)30337-5. doi: 10.1016/j.urolonc.2018.08.017. [Epub ahead of print] Review.

PMID:
30301700
4.

Primitive neuroectodermal tumor arising from an untreated congenital undescended testicle.

Azizi M, Peyton CC, Spiess PE.

Can J Urol. 2018 Oct;25(5):9530-9533.

PMID:
30281013
5.

Biomarkers and new therapeutic targets in renal cell carcinoma.

Di Pietro G, Luu HN, Spiess PE, Sexton W, Dickinson S, Parker A, Park JY.

Eur Rev Med Pharmacol Sci. 2018 Sep;22(18):5874-5891. doi: 10.26355/eurrev_201809_15916.

PMID:
30280768
6.

Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancer.

Poch M, Hall M, Joerger A, Kodumudi K, Beatty M, Innamarato PP, Bunch BL, Fishman MN, Zhang J, Sexton WJ, Pow-Sang JM, Gilbert SM, Spiess PE, Dhillon J, Kelley L, Mullinax J, Sarnaik AA, Pilon-Thomas S.

Oncoimmunology. 2018 Jul 23;7(9):e1476816. doi: 10.1080/2162402X.2018.1476816. eCollection 2018.

7.

The Value of Neutrophil to Lymphocyte Ratio in Patients Undergoing Cytoreductive Nephrectomy with Thrombectomy.

Peyton CC, Abel EJ, Chipollini J, Boulware DC, Azizi M, Karam JA, Margulis V, Master VA, Matin SF, Raman JD, Sexton WJ, Wood CG, Spiess PE.

Eur Urol Focus. 2018 Sep 8. pii: S2405-4569(18)30242-6. doi: 10.1016/j.euf.2018.08.023. [Epub ahead of print]

PMID:
30206003
8.

NCCN Guidelines Insights: Bladder Cancer, Version 5.2018.

Flaig TW, Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Downs TM, Efstathiou JA, Friedlander T, Greenberg RE, Guru KA, Hahn N, Herr HW, Hoimes C, Inman BA, Jimbo M, Kader AK, Lele SM, Meeks JJ, Michalski J, Montgomery JS, Pagliaro LC, Pal SK, Patterson A, Petrylak DP, Plimack ER, Pohar KS, Porter MP, Preston MA, Sexton WJ, Siefker-Radtke AO, Tward J, Wile G, Johnson-Chilla A, Dwyer MA, Gurski LA.

J Natl Compr Canc Netw. 2018 Sep;16(9):1041-1053. doi: 10.6004/jnccn.2018.0072.

PMID:
30181416
9.

Downstaging and Survival Outcomes Associated With Neoadjuvant Chemotherapy Regimens Among Patients Treated With Cystectomy for Muscle-Invasive Bladder Cancer.

Peyton CC, Tang D, Reich RR, Azizi M, Chipollini J, Pow-Sang JM, Manley B, Spiess PE, Poch MA, Sexton WJ, Fishman M, Zhang J, Gilbert SM.

JAMA Oncol. 2018 Aug 30. doi: 10.1001/jamaoncol.2018.3542. [Epub ahead of print]

PMID:
30178038
10.

Simulated management of urinary tract injury during robotic pelvic surgery utilizing the porcine model.

Hoffman MS, Spiess PE.

J Robot Surg. 2018 Jul 16. doi: 10.1007/s11701-018-0852-z. [Epub ahead of print]

PMID:
30014233
11.

Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Penile Squamous Cell Carcinoma Patients Undergoing Inguinal Lymph Node Dissection.

Azizi M, Peyton CC, Boulware DC, Chipollini J, Juwono T, Pow-Sang JM, Spiess PE.

Eur Urol Focus. 2018 Jun 21. pii: S2405-4569(18)30156-1. doi: 10.1016/j.euf.2018.06.008. [Epub ahead of print]

PMID:
29937330
12.

Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy.

Vasdev N, Zargar H, Noël JP, Veeratterapillay R, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Gandhi NM, Griffin J, Montgomery JS, Yu EY, Xylinas E, Campain NJ, Kassouf W, Dall'Era MA, Seah JA, Ercole CE, Horenblas S, Sridhar SS, McGrath JS, Aning J, Shariat SF, Wright JL, Morgan TM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Stephenson AJ, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Holzbeierlein JM, Thorpe A, Black PC.

World J Urol. 2018 Jun 7. doi: 10.1007/s00345-018-2361-0. [Epub ahead of print]

PMID:
29882105
13.

Survival Outcomes Associated With Female Primary Urethral Carcinoma: Review of a Single Institutional Experience.

Peyton CC, Azizi M, Chipollini J, Ercole C, Fishman M, Gilbert SM, Juwono T, Lockhart J, Poch M, Pow-Sang JM, Spiess PE, Wiegand L, Sexton WJ.

Clin Genitourin Cancer. 2018 Oct;16(5):e1003-e1013. doi: 10.1016/j.clgc.2018.05.012. Epub 2018 May 18.

PMID:
29859736
14.

Improved Outcomes of Enhanced Recovery After Surgery (ERAS) Protocol for Radical Cystectomy with Addition of a Multidisciplinary Care Process in a US Comprehensive Cancer Care Center.

Patel SY, Garcia Getting RE, Alford B, Hussein K, Schaible BJ, Boulware D, Lee JK, Gilbert SM, Powsang JM, Sexton WJ, Spiess PE, Poch MA.

World J Surg. 2018 May 10. doi: 10.1007/s00268-018-4665-z. [Epub ahead of print]

PMID:
29750321
15.

Outcomes for Patients with Node-positive Penile Cancer: Impact of Perioperative Systemic Therapies and the Importance of Surgical Intervention.

Chipollini J, Necchi A, Spiess PE.

Eur Urol. 2018 Aug;74(2):241-242. doi: 10.1016/j.eururo.2018.04.025. Epub 2018 May 3. No abstract available.

PMID:
29730019
16.

Treatment Options for Patients with Recurrent Tumors After BCG Therapy: Are We Ignoring the Obvious?

Li R, Spiess PE, Kamat AM.

Eur Urol. 2018 Oct;74(4):405-408. doi: 10.1016/j.eururo.2018.04.012. Epub 2018 Apr 22.

PMID:
29685644
17.

Multi-institutional Survival Analysis of Incidental Pathologic T3a Upstaging in Clinical T1 Renal Cell Carcinoma Following Partial Nephrectomy.

Russell CM, Lebastchi AH, Chipollini J, Niemann A, Mehra R, Morgan TM, Miller DC, Palapattu GS, Hafez KS, Sexton WJ, Spiess PE, Weizer AZ.

Urology. 2018 Jul;117:95-100. doi: 10.1016/j.urology.2018.04.002. Epub 2018 Apr 17.

PMID:
29678662
18.

The relationship between HPV status and chemoradiotherapy in the locoregional control of penile cancer.

Yuan Z, Naghavi AO, Tang D, Kim Y, Ahmed KA, Dhillon J, Giuliano AR, Spiess PE, Johnstone PA.

World J Urol. 2018 Sep;36(9):1431-1440. doi: 10.1007/s00345-018-2280-0. Epub 2018 Mar 27.

PMID:
29589134
19.

Surgical and Oncological Outcomes in Patients After Vascularised Flap Reconstruction for Locoregionally Advanced Penile Cancer.

Ottenhof SR, Leone A, Djajadiningrat RS, Azizi M, Zargar K, Kidd LC, Diorio G, Mosiello G, Graafland NM, Spiess PE, Horenblas S.

Eur Urol Focus. 2018 Feb 9. pii: S2405-4569(18)30026-9. doi: 10.1016/j.euf.2018.02.002. [Epub ahead of print]

PMID:
29433986
20.

Best videos of the year in 2017.

Spiess PE.

Int Braz J Urol. 2018 Jan-Feb;44(1):2-3. doi: 10.1590/S1677-5538.IBJU.2018.0002. No abstract available.

21.

The role of surgery in the management of metastatic kidney cancer: an evidence-based collaborative review.

Mir MC, Matin SF, Bex A, Spiess PE, Thompson RH, Grob B, van Poppel H.

Minerva Urol Nefrol. 2018 Apr;70(2):109-125. doi: 10.23736/S0393-2249.18.03055-2. Epub 2018 Jan 29.

22.

Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical Cystectomy.

Zargar H, Shah JB, van Rhijn BW, Daneshmand S, Bivalacqua TJ, Spiess PE, Black PC, Kassouf W; Collaborators.

J Urol. 2018 Jun;199(6):1452-1458. doi: 10.1016/j.juro.2017.12.062. Epub 2018 Jan 9.

PMID:
29329894
23.

Long-term supplementation of decaffeinated green tea extract does not modify body weight or abdominal obesity in a randomized trial of men at high risk for prostate cancer.

Kumar NB, Patel R, Pow-Sang J, Spiess PE, Salup R, Williams CR, Schell MJ.

Oncotarget. 2017 Jun 29;8(58):99093-99103. doi: 10.18632/oncotarget.18858. eCollection 2017 Nov 17.

24.

Penile sparing surgical approaches for primary penile tumors: preserving function and appearance.

Baumgarten AS, Fisher JS, Lawindy SM, Pavlinec JG, Carrion RE, Spiess PE.

Transl Androl Urol. 2017 Oct;6(5):809-819. doi: 10.21037/tau.2017.04.01. Review.

25.

Relationship between human papillomavirus and penile cancer-implications for prevention and treatment.

Kidd LC, Chaing S, Chipollini J, Giuliano AR, Spiess PE, Sharma P.

Transl Androl Urol. 2017 Oct;6(5):791-802. doi: 10.21037/tau.2017.06.27. Review.

26.

Management of penile cancer.

Spiess PE, Poch MA.

Transl Androl Urol. 2017 Oct;6(5):783-784. doi: 10.21037/tau.2017.09.15. No abstract available.

27.

Survival outcomes of organ sparing surgery, partial penectomy, and total penectomy in pathological T1/T2 penile cancer: Report from the National Cancer Data Base.

Kamel MH, Tao J, Su J, Khalil MI, Bissada NK, Schurhamer B, Spiess PE, Davis R.

Urol Oncol. 2018 Feb;36(2):82.e7-82.e15. doi: 10.1016/j.urolonc.2017.10.017. Epub 2017 Nov 16.

PMID:
29153943
28.

Penile Sparing Surgery for Penile Cancer: A Multicenter International Retrospective Cohort.

Baumgarten A, Chipollini J, Yan S, Ottenhof SR, Tang DH, Draeger D, Protzel C, Zhu Y, Ye DW, Hakenberg OW, Horenblas S, Watkin NA, Spiess PE.

J Urol. 2018 May;199(5):1233-1237. doi: 10.1016/j.juro.2017.10.045. Epub 2017 Nov 11.

PMID:
29132984
29.

Immunotherapy with Checkpoint Blockade in the Treatment of Urothelial Carcinoma.

Siefker-Radtke AO, Apolo AB, Bivalacqua TJ, Spiess PE, Black PC.

J Urol. 2018 May;199(5):1129-1142. doi: 10.1016/j.juro.2017.10.041. Epub 2017 Nov 4. Review. Erratum in: J Urol. 2018 Jul 12;:.

PMID:
29113841
30.

Pathologic Predictors of Survival During Lymph Node Dissection for Metastatic Renal-Cell Carcinoma: Results From a Multicenter Collaboration.

Chipollini J, Abel EJ, Peyton CC, Boulware DC, Karam JA, Margulis V, Master VA, Zargar-Shoshtari K, Matin SF, Sexton WJ, Raman JD, Wood CG, Spiess PE.

Clin Genitourin Cancer. 2018 Apr;16(2):e443-e450. doi: 10.1016/j.clgc.2017.10.004. Epub 2017 Oct 17.

PMID:
29113770
31.

Postchemotherapy lymph node dissection for isolated retroperitoneal nodal recurrences for penile cancer: Is cure possible in highly selected cases?

Tang DH, Chipollini J, Spiess PE.

Urol Oncol. 2018 Jan;36(1):1-3. doi: 10.1016/j.urolonc.2017.07.017. Epub 2017 Aug 18.

PMID:
29108682
32.

Insight into novel biomarkers in penile cancer: Redefining the present and future treatment paradigm?

Zargar-Shoshtari K, Sharma P, Spiess PE.

Urol Oncol. 2018 Oct;36(10):433-439. doi: 10.1016/j.urolonc.2017.10.010. Epub 2017 Nov 2. Review.

PMID:
29103967
33.

Laser ablation as monotherapy for penile squamous cell carcinoma: A multi-center cohort analysis.

Tang DH, Yan S, Ottenhof SR, Draeger D, Baumgarten AS, Chipollini J, Protzel C, Zhu Y, Ye DW, Hakenberg OW, Horenblas S, Watkin NA, Spiess PE.

Urol Oncol. 2018 Apr;36(4):147-152. doi: 10.1016/j.urolonc.2017.09.028. Epub 2017 Oct 31.

PMID:
29097087
34.

Penile cancer: Targeted therapy in penile cancer: a new treatment paradigm.

Azizi M, Spiess PE.

Nat Rev Urol. 2018 Jan;15(1):5-6. doi: 10.1038/nrurol.2017.183. Epub 2017 Oct 31. No abstract available.

PMID:
29089608
35.

Evaluating the accuracy of intraoperative frozen section during inguinal lymph node dissection in penile cancer.

Chipollini J, Tang DH, Manimala N, Gilbert SM, Pow-Sang JM, Sexton WJ, Poch MA, Spiess PE.

Urol Oncol. 2018 Jan;36(1):14.e1-14.e5. doi: 10.1016/j.urolonc.2017.08.018. Epub 2017 Oct 9.

PMID:
29032883
36.

Demographic and socioeconomic predictors of treatment delays, pathologic stage, and survival among patients with penile cancer: A report from the National Cancer Database.

Attalla K, Paulucci DJ, Blum K, Anastos H, Moses KA, Badani KK, Spiess PE, Sfakianos JP.

Urol Oncol. 2018 Jan;36(1):14.e17-14.e24. doi: 10.1016/j.urolonc.2017.09.014. Epub 2017 Oct 12.

PMID:
29031418
37.

Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.

Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Clark PE, Downs TM, Efstathiou JA, Flaig TW, Friedlander T, Greenberg RE, Guru KA, Hahn N, Herr HW, Hoimes C, Inman BA, Jimbo M, Kader AK, Lele SM, Meeks JJ, Michalski J, Montgomery JS, Pagliaro LC, Pal SK, Patterson A, Plimack ER, Pohar KS, Porter MP, Preston MA, Sexton WJ, Siefker-Radtke AO, Sonpavde G, Tward J, Wile G, Dwyer MA, Gurski LA.

J Natl Compr Canc Netw. 2017 Oct;15(10):1240-1267. doi: 10.6004/jnccn.2017.0156.

PMID:
28982750
38.

Surgical management of penile carcinoma in situ: results from an international collaborative study and review of the literature.

Chipollini J, Yan S, Ottenhof SR, Zhu Y, Draeger D, Baumgarten AS, Tang DH, Protzel C, Ye DW, Hakenberg OW, Horenblas S, Watkin NA, Spiess PE.

BJU Int. 2018 Mar;121(3):393-398. doi: 10.1111/bju.14037. Epub 2017 Oct 24. Review.

PMID:
28972681
39.

National Trends and Predictors of Organ-sparing for Invasive Penile Tumors: Expanding the Therapeutic Window.

Chipollini J, Tang DH, Sharma P, Spiess PE.

Clin Genitourin Cancer. 2018 Apr;16(2):e383-e389. doi: 10.1016/j.clgc.2017.09.004. Epub 2017 Sep 8.

PMID:
28967504
40.

Advancements in staging and imaging for penile cancer.

Ottenhof SR, Leone AR, Horenblas S, Spiess PE, Vegt E.

Curr Opin Urol. 2017 Nov;27(6):612-620. doi: 10.1097/MOU.0000000000000447. Review.

PMID:
28937510
41.

Management Strategies and Outcomes for VHL-related Craniospinal Hemangioblastomas.

Ordookhanian C, Kaloostian PE, Ghostine SS, Spiess PE, Etame AB.

J Kidney Cancer VHL. 2017 Aug 28;4(3):37-44. doi: 10.15586/jkcvhl.2017.90. eCollection 2017. Review.

42.

National Trends and Predictors of Locally Advanced Penile Cancer in the United States (1998-2012).

Chipollini J, Chaing S, Peyton CC, Sharma P, Kidd LC, Giuliano AR, Johnstone PA, Spiess PE.

Clin Genitourin Cancer. 2017 Aug 12. pii: S1558-7673(17)30241-0. doi: 10.1016/j.clgc.2017.07.031. [Epub ahead of print]

PMID:
28866244
43.

Glansectomy as Primary Management of Penile Squamous Cell Carcinoma: An International Study Collaboration.

Tang DH, Yan S, Ottenhof SR, Draeger D, Baumgarten AS, Chipollini J, Protzel C, Zhu Y, Ye DW, Hakenberg OW, Horenblas S, Watkin NA, Spiess PE.

Urology. 2017 Nov;109:140-144. doi: 10.1016/j.urology.2017.08.004. Epub 2017 Aug 14.

PMID:
28818536
44.

Advances in Understanding of Penile Carcinogenesis: The Search for Actionable Targets.

Chipollini J, Chaing S, Azizi M, Kidd LC, Kim P, Spiess PE.

Int J Mol Sci. 2017 Aug 16;18(8). pii: E1777. doi: 10.3390/ijms18081777. Review.

45.

Adjuvant pelvic radiation is associated with improved survival and decreased disease recurrence in pelvic node-positive penile cancer after lymph node dissection: A multi-institutional study.

Tang DH, Djajadiningrat R, Diorio G, Chipollini J, Ma Z, Schaible BJ, Catanzaro M, Ye D, Zhu Y, Nicolai N, Horenblas S, Johnstone PAS, Spiess PE.

Urol Oncol. 2017 Oct;35(10):605.e17-605.e23. doi: 10.1016/j.urolonc.2017.06.001. Epub 2017 Jun 27.

PMID:
28666722
46.

Delay to Inguinal Lymph Node Dissection Greater than 3 Months Predicts Poorer Recurrence-Free Survival for Patients with Penile Cancer.

Chipollini J, Tang DH, Gilbert SM, Poch MA, Pow-Sang JM, Sexton WJ, Spiess PE.

J Urol. 2017 Dec;198(6):1346-1352. doi: 10.1016/j.juro.2017.06.076. Epub 2017 Jun 23.

PMID:
28652123
47.

Dose dense MVAC prior to radical cystectomy: a real-world experience.

Zargar H, Shah JB, van de Putte EEF, Potvin KR, Zargar-Shoshtari K, van Rhijn BW, Daneshmand S, Holzbeierlein JM, Spiess PE, Winquist E, Horenblas S, Dinney C, Black PC, Kassouf W.

World J Urol. 2017 Nov;35(11):1729-1736. doi: 10.1007/s00345-017-2065-x. Epub 2017 Jun 17.

PMID:
28625005
48.

Management of Renal Masses in an Octogenarian Cohort: Is There a Right Approach?

Tang DH, Nawlo J, Chipollini J, Gilbert SM, Poch M, Pow-Sang JM, Sexton WJ, Spiess PE.

Clin Genitourin Cancer. 2017 Dec;15(6):696-703. doi: 10.1016/j.clgc.2017.05.011. Epub 2017 May 10.

PMID:
28566202
49.

Patterns of Regional Lymphadenectomy for Clinically Node-negative Patients With Penile Carcinoma: Analysis From the National Cancer Database From 1998 to 2012.

Chipollini J, Tang DH, Sharma P, Baumgarten AS, Spiess PE.

Clin Genitourin Cancer. 2017 Dec;15(6):670-677.e1. doi: 10.1016/j.clgc.2017.04.019. Epub 2017 Apr 26.

PMID:
28522287
50.

Neoadjuvant Chemotherapy in Elderly Patients With Bladder Cancer: Oncologic Outcomes From a Single Institution Experience.

Leone AR, Zargar-Shoshtari K, Diorio GJ, Sharma P, Boulware D, Gilbert SM, Powsang JM, Zhang J, Sexton WJ, Spiess PE, Poch MA.

Clin Genitourin Cancer. 2017 Aug;15(4):e583-e589. doi: 10.1016/j.clgc.2017.01.014. Epub 2017 Feb 1.

PMID:
28410909

Supplemental Content

Loading ...
Support Center